Camden CCG Prescribing Quality Scheme Risk Reduction Review 2018/19 has been developed to reduce the risk of medicines prescribed in primary care. The aims of the risk reduction review are to:
Highlight prescribing related risks
Reduce the risk of occurrence of prescribing errors
Reduce variation (of prescribing risks) between practices
Prevent unnecessary harm
Improve patient safety and health outcomes
Enable practices to embed the review process into internal practice medication safety processes to ensure ongoing identification and review of at risk-patients.
The outcomes were:
45% decrease in number of patients at risk for the WHO patient safety indicators (18 – 75% range)
44% decrease in number of patients at risk for DOAC /warfarin safety indicators (16 – 85% range)
27% decrease overall in patients at risk for the combined 44 indicators of the practices undertaking the review – some indicators 100% decrease.
GP practice action plans point to increased education and awareness of clinical staff, reminders and alerts being included in patient notes, better clinical coding, patients reviewed and medicines changed / monitoring done, safer process for starting medicines and issuing repeat medicines.
